Genomic test helps flag early aggressive prostate cancer in African American patients

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after treatment, particularly African American men who face the highest burden from this disease. The findings were published in the Journal of the National Comprehensive Cancer Network.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup